Track the latest Cyclacel Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Cyclacel Pharmaceuticals stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Feb 28, 2025 | David E Lazar | INTERIM CEO | 0.00 | $0.03 | -$5.51M | SELL-OPTIONS | 0.00% | 0.00 | Feb 26 | View |
Dec 26, 2023 | Paul McBarron | SEE REMARKS | 1.89K | $3.31 | $6.25K | BUY | 5.99% | 33.38K | Dec 21 | View |
Dec 26, 2023 | Spiro Rombotis | PRESIDENT AND CEO | 6.07K | $3.31 | $20.12K | BUY | 9.70% | 68.66K | Dec 21 | View |
Dec 02, 2021 | Sam L Barker | DIRECTOR | -12.00 | $3.57 | -$42.86 | SELL | -0.35% | 3.37K | Nov 30 | View |
Nov 22, 2021 | Spiro Rombotis | PRESIDENT AND CEO | 4.00K | $4.50 | $18.00K | BUY | 404.86% | 4.99K | Nov 18 | View |
Aug 25, 2021 | Sam L Barker | DIRECTOR | 1.00K | $5.00 | $5.00K | BUY | 41.91% | 3.39K | Aug 24 | View |
Browse insider trades on all stocks.